Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
hyperimmune intravenous immunoglobulin (1 trial)
immune globulin (human) (Gamastan) (1 trial)
Trials (1 total)
Trial APIs (2 total)